Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SY-009 capsules in type 2 diabetes mellitus
CTR20220144Phase 2Completed
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yagratide in type 2 diabetes mellitus (T2DM), sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started Jan 2022; status: completed.
02
Drugs
yagratide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20220144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220144.